Evaluation of the Impact of the Use of Hypnotherapy Performed by a Virtual Reality Toolalong the Care Pathway of Patients Undergoing Breast Cancer Treatment.

NAActive, not recruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

September 24, 2020

Primary Completion Date

March 23, 2022

Study Completion Date

January 30, 2024

Conditions
Breast Cancer
Interventions
DEVICE

Oncomfort® clinical virtual reality

"hypnotherapy arm, patients will receive in addition to the care provided by the usual :~* for PAC insertion: a 45-minute hypnotherapy session 2 hours before the procedure in a room of the outpatient surgery unit (UCA).~* during the entire duration of chemotherapy (and/or immunotherapy for HER2+ patients) : one hypnotherapy session before the first treatment and then every 3 weeks. One hypnotherapy session before the first treatment and then every 3 weeks. Thus, sessions will take place before each treatment for 3-week inter-course regimens and every 3 treatments for chemotherapy administered on a weekly. Each session will last 20 minutes."

Trial Locations (1)

75014

Groupe Hospitalier Paris Saint Joseph, Paris

All Listed Sponsors
lead

Fondation Hôpital Saint-Joseph

OTHER